Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases

Prion. 2018 Mar 4;12(2):127-137. doi: 10.1080/19336896.2018.1464367. Epub 2018 May 18.

Abstract

Pin1 is a peptidyl-prolyl isomerase that induces the cis-trans conversion of specific Ser/Thr-Pro peptide bonds in phosphorylated proteins, leading to conformational changes through which Pin1 regulates protein stability and activity. Since down-regulation of Pin1 has been described in several neurodegenerative disorders, including Alzheimer's Disease (AD), Parkinson's Disease (PD) and Huntington's Disease (HD), we investigated its potential role in prion diseases. Animals generated on wild-type (Pin1+/+), hemizygous (Pin1+/-) or knock-out (Pin1-/-) background for Pin1 were experimentally infected with RML prions. The study indicates that, neither the total depletion nor reduced levels of Pin1 significantly altered the clinical and neuropathological features of the disease.

Keywords: PMCA; Pin1; neurodegeneration; prion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • NIMA-Interacting Peptidylprolyl Isomerase / genetics
  • NIMA-Interacting Peptidylprolyl Isomerase / metabolism
  • Peptidylprolyl Isomerase / genetics
  • Peptidylprolyl Isomerase / metabolism*
  • Phosphorylation
  • Prion Diseases / genetics
  • Prion Diseases / metabolism*
  • Prion Proteins / genetics
  • Prion Proteins / metabolism

Substances

  • NIMA-Interacting Peptidylprolyl Isomerase
  • Prion Proteins
  • Peptidylprolyl Isomerase

Grants and funding

This work was supported by the Ministero della Salute (Current Research to FM) and Associazione Italiana Encefalopatie da Prioni (AIEnP).